Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Boyd

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
AIDS (London, England)|July 26, 2011
The development of an expert system to predict virological response to HIV therapy as part of an online treatment support toolAndrew D Revell, Dechao Wang, Mark A Boyd, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapyHila Haskelberg, Patrick W G Mallon, Jennifer Hoy, et al.
Journal of Clinical Epidemiology|January 14, 2026
'Identifying Social Factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in Pain Research': Explanation and elaboration to support the standardised reporting of equity-relevant dataEmma L Karran, Aidan G Cashin, Alessandro Chiarotto, et al.
The Journal of Pain|December 25, 2025
Standardising socio-demographic data collection in pain research: Introducing consensus recommendations for a minimum datasetEmma L Karran, Aidan G Cashin, Alessandro Chiarotto, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjectsMark A Boyd, Rob E Aarnoutse, Kiat Ruxrungtham, et al.
European Journal of Pain (London, England)|December 19, 2025
Standardising the Collection of Socio-Demographic Data in Pain ResearchEmma L Karran, Aidan G Cashin, Alessandro Chiarotto, et al.
Frontiers in Immunology|June 17, 2021
Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV InfectionGerald Mak, John J Zaunders, Michelle Bailey, et al.
The Journal of Infectious Diseases|October 17, 2006
Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012)Mark A Boyd, Narendra M Dixit, Umaporn Siangphoe, et al.
Pharmacogenetics and Genomics|April 13, 2006
Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavirMark A Boyd, Preeyaporn Srasuebkul, Kiat Ruxrungtham, et al.
Journal of Clinical Epidemiology|October 6, 2023
Using PROGRESS-plus to identify current approaches to the collection and reporting of equity-relevant data: a scoping reviewEmma L Karran, Aidan G Cashin, Trevor Barker, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|July 26, 2011
The development of an expert system to predict virological response to HIV therapy as part of an online treatment support toolAndrew D Revell, Dechao Wang, Mark A Boyd, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapyHila Haskelberg, Patrick W G Mallon, Jennifer Hoy, et al.
Journal of Clinical Epidemiology|January 14, 2026
'Identifying Social Factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in Pain Research': Explanation and elaboration to support the standardised reporting of equity-relevant dataEmma L Karran, Aidan G Cashin, Alessandro Chiarotto, et al.
The Journal of Pain|December 25, 2025
Standardising socio-demographic data collection in pain research: Introducing consensus recommendations for a minimum datasetEmma L Karran, Aidan G Cashin, Alessandro Chiarotto, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjectsMark A Boyd, Rob E Aarnoutse, Kiat Ruxrungtham, et al.
European Journal of Pain (London, England)|December 19, 2025
Standardising the Collection of Socio-Demographic Data in Pain ResearchEmma L Karran, Aidan G Cashin, Alessandro Chiarotto, et al.
Frontiers in Immunology|June 17, 2021
Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV InfectionGerald Mak, John J Zaunders, Michelle Bailey, et al.
The Journal of Infectious Diseases|October 17, 2006
Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012)Mark A Boyd, Narendra M Dixit, Umaporn Siangphoe, et al.
Pharmacogenetics and Genomics|April 13, 2006
Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavirMark A Boyd, Preeyaporn Srasuebkul, Kiat Ruxrungtham, et al.
Journal of Clinical Epidemiology|October 6, 2023
Using PROGRESS-plus to identify current approaches to the collection and reporting of equity-relevant data: a scoping reviewEmma L Karran, Aidan G Cashin, Trevor Barker, et al.
Pageof 10